<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Restless legs syndrome during pregnancy and lactation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Restless legs syndrome during pregnancy and lactation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Restless legs syndrome during pregnancy and lactation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel L Picchietti, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alon Y Avidan, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            April F Eichler, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 27, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H111903028">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Restless legs syndrome (RLS) is very common during pregnancy, affecting approximately one in five individuals. Symptom severity varies widely, from a minor nuisance in some to severe, disruptive symptoms in others. Symptoms typically peak during the third trimester and remit or markedly improve after delivery.
        </p>
        <p>
         RLS commonly impacts sleep during pregnancy, and accumulating data indicate that RLS symptoms are associated with increased risk for adverse pregnancy outcomes.
        </p>
        <p>
         This topic will review aspects of the diagnosis and treatment of RLS that are unique to pregnancy. Clinical features, diagnosis, and treatment of RLS in the general population are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">
          "Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">
          "Management of restless legs syndrome and periodic limb movement disorder in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16995.html" rel="external">
          "Restless legs syndrome and periodic limb movement disorder in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903035">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence and incidence
         </strong>
         – The prevalence of restless legs syndrome (RLS) during pregnancy is two- to threefold higher than the prevalence in the general population [
         <a href="#rid1">
          1-5
         </a>
         ]. In a meta-analysis of 27 studies in over 50,000 pregnant people, the pooled prevalence of RLS across all three trimesters of pregnancy was 21 percent [
         <a href="#rid6">
          6
         </a>
         ]. Similarly, the incidence of new-onset RLS during pregnancy is 18 percent [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Prevalence varies by geographic region. Estimates range from approximately 20 percent in Europe and the Americas, 30 percent in the Eastern Mediterranean region, 14 percent in the Western Pacific Rim, and 4 to 5 percent in Japan, for example [
         <a href="#rid2">
          2,6,8-11
         </a>
         ]. A single study from Africa (Nigeria) found no cases in a study population of 310 pregnant individuals [
         <a href="#rid12">
          12
         </a>
         ]. However, in a large multiracial cohort from the United States, race was not found to be a significant risk factor for RLS during pregnancy [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – The majority of cases are of new onset during pregnancy (gestational RLS), with preexisting RLS accounting for 4 to 33 percent of cases [
         <a href="#rid3">
          3,13-18
         </a>
         ]. Risk factors for RLS during pregnancy include preexisting RLS, a family history of RLS, RLS during a prior pregnancy, age ≥35 years, tobacco use, low serum ferritin, and iron deficiency anemia [
         <a href="#rid13">
          13,17,19-25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H968296152">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Genetics, brain iron deficiency, and brain dopamine have been implicated in the pathophysiology of restless legs syndrome (RLS) in the general population. (See
         <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">
          "Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p>
         Factors specific to pregnancy have not yet been adequately defined. Iron deficiency, decreased iron availability, vitamin D deficiency, folate deficiency, familial predisposition, high estrogen levels, and stretch/compression of nerves have been postulated, but the limited evidence is conflicting [
         <a href="#rid26">
          26-31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H968296089">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The symptoms of restless legs syndrome (RLS) during pregnancy are the same as those in the general population but follow a unique course, with a tendency to escalate over the course of pregnancy and spontaneously remit shortly after delivery.
        </p>
        <p class="headingAnchor" id="H968296095">
         <span class="h2">
          Symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         The hallmark symptom of RLS is an urge to move the legs that occurs at rest and is relieved by movement, as long as the movement continues. The need to move is usually, but not always, accompanied by other uncomfortable sensations in the legs. Terms that individuals use to describe RLS include "have to move," "need to move," "can't get comfortable," "creepy-crawly," "aching," "bug-like," "itching," and "antsy," typically localizing to the lower extremities but also sometimes to the upper extremities. Symptoms usually worsen in the evening or at night, and commonly interfere with quiet activities and sleep. (See
         <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">
          "Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
         The severity of RLS symptoms during pregnancy varies widely. In large cohort studies, the proportion of pregnant individuals reporting severe to very severe symptoms on a standardized RLS rating scale ranges from approximately 15 to 50 percent [
         <a href="#rid3">
          3,15,32-34
         </a>
         ]. In the study with the lowest proportion of severe cases, 70 percent of patients reported at least moderate symptom severity [
         <a href="#rid15">
          15,34
         </a>
         ].
        </p>
        <p>
         RLS is the third most common reason for insomnia during pregnancy (after nocturia and positional discomfort), affecting both sleep onset and maintenance [
         <a href="#rid16">
          16,22,33,35-37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H968296101">
         <span class="h2">
          Clinical course during pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both the prevalence and severity of RLS steadily increase over the course of pregnancy, peaking at the seventh to eighth month [
         <a href="#rid14">
          14,16,35,38,39
         </a>
         ]. Pooled prevalence rates for the first, second, and third trimesters were found to be 8, 16, and 22 percent, respectively [
         <a href="#rid6">
          6
         </a>
         ]. Approximately 70 percent of affected patients experience complete resolution shortly after delivery, and most others experience clear-cut improvement.
        </p>
        <p>
         Although the short-term remission rate for pregnancy-onset cases appears to exceed 90 percent, individuals who have had the transient form of RLS during pregnancy have a fourfold risk for developing nonpregnancy RLS later in life [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H631067270">
         <span class="h2">
          Pregnancy outcomes
         </span>
         <span class="headingEndMark">
          —
         </span>
         RLS during pregnancy is associated with poor sleep quality and decreased physical and mental health quality of life, reflecting similar data for RLS in the general population [
         <a href="#rid1">
          1,32,41,42
         </a>
         ]. More frequent maternal complications reported are gestational hypertension, preeclampsia, gestational diabetes mellitus, and peripartum depression [
         <a href="#rid43">
          43,44
         </a>
         ]. However, impact of RLS treatment on these outcomes has not been studied adequately.
        </p>
        <p class="headingAnchor" id="H968296108">
         <span class="h2">
          Psychiatric comorbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         RLS often co-occurs with depression and anxiety in adults [
         <a href="#rid45">
          45-51
         </a>
         ]. In a large population-based study in the general population, RLS was associated with a significantly increased risk for major depressive disorder (odds ratio [OR] 5) and panic disorder (OR 13) [
         <a href="#rid48">
          48
         </a>
         ]. More limited data support these associations in pregnant people as well [
         <a href="#rid44">
          44,52-55
         </a>
         ].
        </p>
        <p>
         Psychiatric comorbidity is important to recognize in pregnant patients with RLS because it can significantly influence the treatment plan. (See
         <a class="local">
          'Refractory symptoms'
         </a>
         below and
         <a class="local">
          'Comorbid depression'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H111903049">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Restless legs syndrome (RLS) is a clinical diagnosis that should be suspected in individuals who complain of an urge to move the legs when lying in bed or sitting down. The diagnosis is made by history and does not require additional testing, except for an assessment of iron status (even among women who are not anemic) to determine whether iron replacement is indicated. Polysomnography is not required for the diagnosis.
        </p>
        <p>
         Diagnostic criteria for RLS demonstrate the essential clinical features of RLS, all of which are required for the diagnosis  (
         <a class="graphic graphic_table graphicRef86837" href="/z/d/graphic/86837.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid56">
          56,57
         </a>
         ]. Often, the simple prompt "Do your legs bother you when you are sitting or lying down?" will initiate a focused dialogue that allows the clinician to assess each of the essential criteria and exclude mimics of RLS during pregnancy, such as nocturnal leg cramps. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         The severity of symptoms and their impact on functioning should be documented. The clinical significance of RLS is particularly important to identify because it guides the need for therapies beyond reassurance and possible nonpharmacologic interventions. A 10-question RLS severity scale can be useful clinically and is available
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Firlssg.wildapricot.org%2F&amp;token=gOyhYa%2BXujLiCHJ%2FCNa6lRVlEA36kq161lomhyx5zVGNM91TYnFRjWFUUzMDK9Z4&amp;TOPIC_ID=98366" target="_blank">
          online
         </a>
         [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H111903063">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of common and uncommon conditions can mimic restless legs syndrome (RLS) during pregnancy. Most can be excluded by history  (
         <a class="graphic graphic_table graphicRef100457" href="/z/d/graphic/100457.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid2">
          2,59
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Positional leg discomfort is easily relieved by simple position change, rather than the recurrent movements needed to mitigate RLS symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nocturnal leg cramps are common during pregnancy and are characterized by sudden, painful tightness and palpable hardening of the muscle. Unlike in RLS, movement usually worsens the pain of leg cramps, at least initially. (See
         <a class="medical medical_review" href="/z/d/html/427.html" rel="external">
          "Maternal adaptations to pregnancy: Musculoskeletal changes and pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Many of the other mimics, including leg edema, dermatitis, and sore muscles, are characterized by pain or discomfort but
         <strong>
          not
         </strong>
         a need to move the legs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Numbness is not a typical descriptor of RLS, which helps to distinguish it from positional ischemia and neuropathy.
        </p>
        <p>
        </p>
        <p>
         While the diagnostic criteria for RLS require that symptoms cannot be solely accounted for by another primary condition, RLS can co-occur with other primary conditions, including leg cramps or even neuropathy. This necessitates a separate focus on each possible condition in the diagnostic process and in the assessment of impact [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H111903077">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of restless legs syndrome (RLS) during pregnancy should be individualized based on symptom severity, comorbidities such as depression or anxiety, and patient preferences.
        </p>
        <p>
         Many patients can be managed successfully with education, reassurance, iron supplementation if indicated, and nonpharmacologic strategies. Pharmacologic therapies such as
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         or
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          carbidopa-levodopa
         </a>
         may be considered for severe symptoms.
        </p>
        <p class="headingAnchor" id="H968297186">
         <span class="h2">
          Consensus guidelines and algorithm
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consensus clinical practice guidelines and an algorithm for the diagnosis and treatment of RLS during pregnancy and lactation are available  (
         <a class="graphic graphic_algorithm graphicRef100458" href="/z/d/graphic/100458.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ]. The approach outlined below is consistent with these guidelines and other reviews [
         <a href="#rid60">
          60,61
         </a>
         ].
        </p>
        <p>
         Due to a lack of any controlled trials for treatments of RLS during pregnancy and lactation, recommendations for pharmacologic therapy in patients with refractory symptoms are based on results of randomized trials for RLS in the nonpregnant population, limited efficacy data for treatments used during pregnancy, substantial data on the safety of RLS treatments that are used during pregnancy for another indication (eg,
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         for epilepsy and pain, dopaminergics for pituitary adenoma), and the combined clinical experience of the panel [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Of note, only four pharmacologic therapies have specific approval for RLS by the US Food and Drug Administration (FDA) (
         <a class="drug drug_general" data-topicid="10246" href="/z/d/drug information/10246.html" rel="external">
          ropinirole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9560" href="/z/d/drug information/9560.html" rel="external">
          pramipexole
         </a>
         ,
         <a class="drug drug_general" data-topicid="83322" href="/z/d/drug information/83322.html" rel="external">
          rotigotine
         </a>
         patch, and
         <a class="drug drug_general" data-topicid="16486" href="/z/d/drug information/16486.html" rel="external">
          gabapentin enacarbil
         </a>
         ), with caution for all recommended during pregnancy and lactation. The FDA letter risk category system for pregnancy and lactation has been retired and will not be emphasized in this topic [
         <a href="#rid62">
          62,63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H968296696">
         <span class="h2">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment decisions for RLS during pregnancy and lactation should be approached in a collaborative and individualized manner. The following general points are worth considering and reviewing with patients:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Knowledge of the typical clinical course can be reassuring, especially the expected marked decrease in symptoms after delivery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonpharmacologic interventions and iron supplementation are the primary treatment approach.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment decisions must take into consideration symptom severity, impact on functioning, and the known risks and benefits of potential interventions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The placebo effect is common in RLS and other central nervous system disorders (approximately 20 to 40 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When medications are prescribed, aim to use the lowest effective dose and the shortest duration possible. Symptoms should be reassessed periodically, especially after iron stores are replete and after delivery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a 3 to 5 percent chance of any congenital anomaly and a 1 to 3 percent chance of a major congenital anomaly for any pregnancy. The teratogenic risk of any drug is greatest in the first trimester, when organogenesis is primarily occurring. Transplacental passage of drugs in the second or third trimester is less likely to cause a congenital anomaly but can have fetal effects, such as growth impairment and laboratory abnormalities similar to those in the mother.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H111903091">
         <span class="h1">
          FIRST-LINE THERAPIES
         </span>
        </p>
        <p class="headingAnchor" id="H968296742">
         <span class="h2">
          Nonpharmacologic therapy
         </span>
        </p>
        <p class="headingAnchor" id="H111903098">
         <span class="h3">
          Physical exercise
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the absence of contraindications, moderate-intensity physical exercise is encouraged for all pregnant and postpartum individuals. (See
         <a class="medical medical_review" href="/z/d/html/412.html" rel="external">
          "Exercise during pregnancy and the postpartum period"
         </a>
         .)
        </p>
        <p>
         Exercise has been shown to increase deep sleep, improve restless legs syndrome (RLS) symptoms, and benefit mental health, especially depression [
         <a href="#rid64">
          64-67
         </a>
         ]. Brisk walking, water aerobics, ballroom dancing, and general gardening are examples of moderate-intensity exercise. However, even low-intensity exercise like walking may be beneficial for health during pregnancy [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H111903105">
         <span class="h3">
          Avoidance of exacerbating factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assessing for factors that may aggravate RLS and working to reduce these is an important component of nonpharmacologic therapy  (
         <a class="graphic graphic_table graphicRef100630" href="/z/d/graphic/100630.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
         Known or suspected exacerbating factors include iron deficiency (see
         <a class="local">
          'Iron supplementation'
         </a>
         below), insufficient sleep, irregular sleep, pain, caffeine, and nicotine [
         <a href="#rid69">
          69,70
         </a>
         ]. Some medications, including sedating antihistamines, serotonergic antidepressants, and dopamine blockers, can aggravate RLS [
         <a href="#rid69">
          69-72
         </a>
         ]. This includes many drugs used to treat nausea and vomiting of pregnancy (eg,
         <a class="drug drug_general" data-topicid="8796" href="/z/d/drug information/8796.html" rel="external">
          doxylamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">
          prochlorperazine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9820" href="/z/d/drug information/9820.html" rel="external">
          promethazine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">
          metoclopramide
         </a>
         ).
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          Ondansetron
         </a>
         , however, does not appear to trigger RLS symptoms.
        </p>
        <p>
         Treatment of sleep apnea during pregnancy is important to mitigate a variety of potential consequences [
         <a href="#rid73">
          73
         </a>
         ] and may also be of direct benefit for RLS [
         <a href="#rid74">
          74-76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14202.html" rel="external">
          "Obstructive sleep apnea in pregnancy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H773529105">
         <span class="h3">
          Sleep hygiene training
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two face-to-face sessions of sleep hygiene training were found to significantly improve sleep quality, as measured by the Pittsburgh Sleep Quality Index, in pregnant individuals with RLS [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H968296843">
         <span class="h3">
          Other approaches
         </span>
         <span class="headingEndMark">
          —
         </span>
         Additional low-risk strategies that can help RLS symptoms based on small studies include yoga [
         <a href="#rid78">
          78,79
         </a>
         ], massage [
         <a href="#rid80">
          80,81
         </a>
         ], acupuncture, pneumatic compression devices [
         <a href="#rid82">
          82-86
         </a>
         ], and progressive muscle relaxation [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Immersion of the legs in warm or cold water was shown to be of benefit for RLS during pregnancy in a randomized trial [
         <a href="#rid88">
          88
         </a>
         ]. Although many patients mention warm or hot baths as beneficial for RLS, hyperthermia (body temperature above 101°F [38.3°C]) in early pregnancy may be associated with an increased risk of neural tube defects. Therefore, exposure for longer than 10 minutes to heat sources such as hot tubs, very hot baths, or saunas should be avoided. (See
         <a class="medical medical_review" href="/z/d/html/460.html" rel="external">
          "Neural tube defects: Overview of prenatal screening, evaluation, and pregnancy management", section on 'Risk factors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903112">
         <span class="h2">
          Iron supplementation
         </span>
         <span class="headingEndMark">
          —
         </span>
         We recommend assessing iron status in all pregnant individuals with RLS and beginning oral iron supplementation if the serum ferritin level is &lt;75 mcg/L [
         <a href="#rid2">
          2
         </a>
         ]. Maternal serum ferritin drops to approximately 50 percent at midgestation in the absence of iron supplementation due to expanding maternal red blood cell mass, as well as growth of the fetus and placental structures [
         <a href="#rid89">
          89
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7148.html" rel="external">
          "Treatment of iron deficiency anemia in adults", section on 'Pregnancy'
         </a>
         .)
        </p>
        <p>
         Oral iron supplementation is considered safe during pregnancy and lactation [
         <a href="#rid63">
          63,89,90
         </a>
         ]. Intravenous iron may be needed if oral iron is not tolerated or is ineffective. (See
         <a class="local">
          'Oral iron'
         </a>
         below and
         <a class="local">
          'Intravenous iron'
         </a>
         below.)
        </p>
        <p>
         This approach is supported by multiple lines of evidence that implicate iron deficiency in the pathogenesis of RLS, direct evidence that iron supplementation is beneficial in nonpregnancy RLS [
         <a href="#rid91">
          91
         </a>
         ], and more limited evidence for benefit in pregnancy-related RLS [
         <a href="#rid92">
          92-95
         </a>
         ]. Increasing iron stores to the mid-normal range (ferritin &gt;75 mcg/L) appears to optimize brain iron function in RLS. (See
         <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">
          "Management of restless legs syndrome and periodic limb movement disorder in adults", section on 'Iron replacement'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903119">
         <span class="h3">
          Iron assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         We assess iron status in all pregnant individuals with RLS, given the evidence for iron's role in the pathophysiology and treatment of this disorder. This includes measurement of hemoglobin, serum ferritin level, iron, total iron binding capacity (TIBC), and percent iron saturation. Results are most accurate if a morning fasting blood sample is obtained off of supplemental iron for one to two days.
        </p>
        <p>
         Serum ferritin is the best single measure of iron stores. However, serum ferritin is an acute phase reactant, and false elevation can occur for up to four weeks after febrile illness [
         <a href="#rid96">
          96
         </a>
         ]. If there is suspicion for chronic inflammation, then C-reactive protein can document it, and less sensitive iron measures such as percent iron saturation and TIBC may be helpful. Empiric iron supplementation without measurement of ferritin is discouraged in order to avoid the rare but serious complication of iron overload. (See
         <a class="local">
          'Oral iron'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H111903126">
         <span class="h3">
          Oral iron
         </span>
         <span class="headingEndMark">
          —
         </span>
         For individuals with RLS and a serum ferritin &lt;75 mcg/L during pregnancy or lactation, we administer and monitor oral iron supplementation as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8444" href="/z/d/drug information/8444.html" rel="external">
          Ferrous sulfate
         </a>
         – 65 mg of elemental iron per tablet, one tablet daily [
         <a href="#rid90">
          90
         </a>
         ]. Alternatively, one or two tablets every other day may produce similar results with fewer side effects [
         <a href="#rid76">
          76,97,98
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7148.html" rel="external">
          "Treatment of iron deficiency anemia in adults", section on 'Dosing and administration (oral iron)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/115637.html" rel="external">
          "Anemia in pregnancy", section on 'Oral iron'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Optimize iron absorption.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Take the iron at night, when brain iron uptake may be higher [
         <a href="#rid76">
          76,99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Take on an empty stomach.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Take iron separately from calcium-containing foods and beverages, calcium supplements, and antacids.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We do not routinely advise patients to take
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         because no high-quality data support the practice, and concerns about the safety of vitamin C during pregnancy have been raised in some studies [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recheck serum ferritin in six to eight weeks.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Discuss possible adverse effects, including nausea, constipation, stomach upset, and diarrhea.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If nausea occurs, take the iron with food.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Drink extra water and avoid dehydration to reduce the risk of constipation.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If constipation occurs, can begin
         <a class="drug drug_general" data-topicid="9382" href="/z/d/drug information/9382.html" rel="external">
          docusate
         </a>
         or polyethylene glycol.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Review safe storage of iron to prevent accidental ingestion in children, which can be lethal. (See
         <a class="medical medical_review" href="/z/d/html/6498.html" rel="external">
          "Acute iron poisoning"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Importantly, the use of therapeutic doses of iron should be limited to medically supervised settings to avoid the rare but very serious complication of iron overload, which can occur in individuals with RLS who carry hemochromatosis genes [
         <a href="#rid101">
          101,102
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H111903133">
         <span class="h3">
          Intravenous iron
         </span>
         <span class="headingEndMark">
          —
         </span>
         Constipation and bloating are common problems with oral iron during pregnancy due to altered gastrointestinal tract function. As a result, intravenous (IV) iron may be needed during pregnancy [
         <a href="#rid90">
          90,103,104
         </a>
         ].
        </p>
        <p>
         In patients with refractory symptoms in the second or third trimester or postpartum period, we generally proceed with IV iron therapy if there is not good progress with oral iron and serum ferritin is &lt;30 mcg/L [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         In addition to generally supportive data in nonpregnant adults with RLS, several small open-label studies have reported benefit of IV iron for pregnancy-related RLS [
         <a href="#rid92">
          92-94
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">
          "Management of restless legs syndrome and periodic limb movement disorder in adults", section on 'Iron replacement'
         </a>
         .)
        </p>
        <p>
         Specific dosing and safety recommendations for RLS [
         <a href="#rid76">
          76
         </a>
         ] and for the administration of IV iron during pregnancy are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/115637.html" rel="external">
          "Anemia in pregnancy", section on 'Intravenous iron'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903140">
         <span class="h1">
          REFRACTORY SYMPTOMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nonpharmacologic treatments should be the primary approach to restless legs syndrome (RLS) during pregnancy and lactation. In some patients, however, the symptoms will be severe and frequent enough despite nonpharmacologic therapies to warrant consideration of medication.
        </p>
        <p>
         Refractory RLS during pregnancy and lactation is defined as an inadequate response to at least one nonpharmacologic intervention and iron (if ferritin &lt;75 mcg/L), tried over an adequate period of time [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Nonpharmacologic therapy'
         </a>
         above and
         <a class="local">
          'Iron supplementation'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H111903147">
         <span class="h2">
          Medications during pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         For refractory RLS (ie, symptoms are not effectively treated with iron supplementation and behavioral therapies) that has a significant impact on quality of life, we suggest use of either low-dose
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         or low-dose
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          carbidopa-levodopa
         </a>
         in patients who wish to try medication [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          Clonazepam
         </a>
         – A typical starting dose of clonazepam is 0.25 mg orally in the evening. Doses between 0.25 mg and 1 mg are typically sufficient [
         <a href="#rid105">
          105,106
         </a>
         ]. Higher doses are not recommended to avoid the risk of neonatal sedation [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A conservative approach suggests that
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         should not be used before the second trimester and avoided in combination with
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         , anticonvulsants, or other central nervous system depressants [
         <a href="#rid2">
          2,107
         </a>
         ]. Evidence for oronasal clefts associated with benzodiazepines in general was not confirmed in subsequent studies, and data specific to clonazepam risk during pregnancy are reassuring [
         <a href="#rid107">
          107-110
         </a>
         ]. Clonazepam may be particularly beneficial in patients with comorbid anxiety.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          Carbidopa-levodopa
         </a>
         – A typical starting dose of carbidopa-levodopa ER is one 25/100 mg tablet in the evening. Doses higher than one 50/200 mg tablet should be avoided to reduce the risk of augmentation. (See
         <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">
          "Management of restless legs syndrome and periodic limb movement disorder in adults", section on 'Augmentation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          Carbidopa-levodopa
         </a>
         use during pregnancy has been described in 38 cases of RLS and 18 cases of Parkinson disease or dopa-responsive dystonia, without evidence for major malformations or other adverse outcomes [
         <a href="#rid111">
          111-113
         </a>
         ]. Combining levodopa with benserazide should be avoided during pregnancy due to a possible adverse effect on bone development [
         <a href="#rid63">
          63,114
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Individuals taking
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          carbidopa-levodopa
         </a>
         should be monitored for the development of augmentation [
         <a href="#rid115">
          115
         </a>
         ] or impulse control problems (see
         <a class="medical medical_review" href="/z/d/html/88241.html" rel="external">
          "Management of restless legs syndrome and periodic limb movement disorder in adults", section on 'Augmentation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4896.html" rel="external">
          "Initial pharmacologic treatment of Parkinson disease", section on 'Impulse control disorders'
         </a>
         ) [
         <a href="#rid116">
          116
         </a>
         ]. Food can delay absorption but may help manage any nausea with levodopa. Carbidopa-levodopa inhibits lactation via suppression of prolactin, but prolactin levels rebound quickly after discontinuation [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The necessity of any medication prescribed for RLS during pregnancy should be reassessed periodically, including at the time of delivery, when symptoms typically abate.
        </p>
        <p>
         Very severe, very refractory RLS during pregnancy is rare, especially if iron status is addressed appropriately. Low-dose
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         is an option after the first trimester, with careful consideration of risks and adequate safety precautions, if iron, nonpharmacologic intervention, and non-opioid treatment have failed  (
         <a class="graphic graphic_algorithm graphicRef100458" href="/z/d/graphic/100458.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid2">
          2,76,117
         </a>
         ].
        </p>
        <p>
         Other medication options more commonly used in nonpregnant adults with RLS, including dopamine agonists and gabapentinoids (eg,
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         ,
         <a class="drug drug_general" data-topicid="16486" href="/z/d/drug information/16486.html" rel="external">
          gabapentin enacarbil
         </a>
         ,
         <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">
          pregabalin
         </a>
         ), are
         <strong>
          not
         </strong>
         recommended for RLS during pregnancy based on a paucity of safety data compared with alternative therapies. The safety of dopamine agonists (eg,
         <a class="drug drug_general" data-topicid="9560" href="/z/d/drug information/9560.html" rel="external">
          pramipexole
         </a>
         ,
         <a class="drug drug_general" data-topicid="10246" href="/z/d/drug information/10246.html" rel="external">
          ropinirole
         </a>
         ,
         <a class="drug drug_general" data-topicid="83322" href="/z/d/drug information/83322.html" rel="external">
          rotigotine
         </a>
         ) has not been well studied during pregnancy, and there are more safety data to support use of the alternative dopaminergic therapy,
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          carbidopa-levodopa
         </a>
         [
         <a href="#rid2">
          2
         </a>
         ]. Available data on the fetal effects of gabapentinoids and other antiseizure medications are reviewed separately [
         <a href="#rid118">
          118-120
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2218.html" rel="external">
          "Risks associated with epilepsy during pregnancy and the postpartum period", section on 'Effects of ASMs on the fetus and child'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903154">
         <span class="h2">
          Medications during lactation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Due to the typical improvement or remission of RLS symptoms after delivery, medication is seldom needed during lactation. However, patients with preexisting RLS may have ongoing symptoms during lactation. In other individuals, significant blood loss during delivery can trigger an increase or persistence of RLS symptoms.
        </p>
        <p>
         For patients with refractory RLS who are breastfeeding, we suggest the following [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reassess iron status
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          Gabapentin
         </a>
         300 to 900 mg in the evening or before sleep, or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low-dose
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         0.25 to 1 mg in the evening
        </p>
        <p>
        </p>
        <p>
         For
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         , the infant is estimated to receive only 1 to 4 percent of the maternal weight-adjusted dose in breast milk, and adverse effects have not been observed in exposed neonates [
         <a href="#rid121">
          121-123
         </a>
         ].
        </p>
        <p>
         Safety data for
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         use during lactation come primarily from case series, which have not found evidence of infant sedation or withdrawal [
         <a href="#rid124">
          124,125
         </a>
         ]. In one series of 11 breastfeeding individuals on a dose of 0.25 to 2 mg clonazepam daily, none of the infants had any reported side effects, and 10 of 11 infants had no measurable serum concentration of clonazepam [
         <a href="#rid125">
          125
         </a>
         ].
        </p>
        <p>
         For both
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         and
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         , caution regarding maternal sedation is warranted during treatment initiation, and concomitant use of other central nervous system depressants, including alcohol, should be avoided. Infants should be carefully observed for excess sedation as well, with additional caution if an infant is born prematurely or is ill.
        </p>
        <p>
         Although opioids may be considered for refractory RLS in adults, opioid use during breastfeeding is discouraged due to potential adverse effects, including respiratory depression, in exposed infants [
         <a href="#rid126">
          126
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H111903161">
         <span class="h1">
          COMORBID DEPRESSION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depression occurs in approximately 7 to 10 percent of pregnant and postpartum individuals, and the risk may be higher among patients with comorbid restless legs syndrome (RLS) [
         <a href="#rid52">
          52-54
         </a>
         ]. Depression during pregnancy has been associated with an increased risk of multiple adverse outcomes, including preeclampsia, substance abuse, miscarriage, preterm delivery, low birth weight, neonaticide, and maternal suicide. (See
         <a class="medical medical_review" href="/z/d/html/1718.html" rel="external">
          "Unipolar major depression during pregnancy: Epidemiology, clinical features, assessment, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1704.html" rel="external">
          "Postpartum unipolar major depression: Epidemiology, clinical features, assessment, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Treatment of RLS may help alleviate depressive and anxiety symptoms [
         <a href="#rid46">
          46,127-129
         </a>
         ]. Nonetheless, specific treatment for depression is typically needed if mood symptoms are prominent. (See
         <a class="medical medical_review" href="/z/d/html/1703.html" rel="external">
          "Severe antenatal unipolar major depression: Choosing treatment"
         </a>
         .)
        </p>
        <p>
         When pharmacologic therapy is being considered, it is important to keep in mind that serotonergic antidepressants can worsen RLS [
         <a href="#rid71">
          71,72,130
         </a>
         ]. For this reason, we typically prefer a nonserotonergic antidepressant such as
         <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">
          bupropion
         </a>
         , which does not exacerbate RLS symptoms [
         <a href="#rid71">
          71,131,132
         </a>
         ].
        </p>
        <p>
         Although there is controversy over the relative risks of different antidepressants,
         <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">
          bupropion
         </a>
         is generally considered to be a reasonable choice during pregnancy and lactation, with attention to the lowest effective dose and, if possible, avoidance during the first trimester [
         <a href="#rid2">
          2,133
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1703.html" rel="external">
          "Severe antenatal unipolar major depression: Choosing treatment", section on 'Treatment-refractory patients'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903168">
         <span class="h1">
          PRECONCEPTION MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pre-pregnancy counseling is important for patients with preexisting restless legs syndrome (RLS) [
         <a href="#rid2">
          2
         </a>
         ]. Topics of discussion should include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The typical clinical course of RLS during pregnancy, including the expected peak in the third trimester and drop back to baseline near delivery (see
         <a class="local">
          'Clinical course during pregnancy'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The range of treatment options during pregnancy (see
         <a class="local">
          'Treatment'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The risks and benefits of continuing medications for RLS during pregnancy (see
         <a class="local">
          'Medications during pregnancy'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The adequacy of iron stores (see
         <a class="local">
          'Iron assessment'
         </a>
         above)
        </p>
        <p>
        </p>
        <p>
         Pending additional safety data, we advise patients to taper
         <a class="drug drug_general" data-topicid="9560" href="/z/d/drug information/9560.html" rel="external">
          pramipexole
         </a>
         ,
         <a class="drug drug_general" data-topicid="10246" href="/z/d/drug information/10246.html" rel="external">
          ropinirole
         </a>
         ,
         <a class="drug drug_general" data-topicid="83322" href="/z/d/drug information/83322.html" rel="external">
          rotigotine
         </a>
         ,
         <a class="drug drug_general" data-topicid="16486" href="/z/d/drug information/16486.html" rel="external">
          gabapentin enacarbil
         </a>
         ,
         <a class="drug drug_general" data-topicid="9473" href="/z/d/drug information/9473.html" rel="external">
          pregabalin
         </a>
         , and
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         prior to a planned pregnancy or, for unplanned pregnancies, at the time pregnancy is confirmed [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Medications during pregnancy'
         </a>
         above.)
        </p>
        <p>
         Due to an anticipated 50 percent drop in maternal serum ferritin during pregnancy [
         <a href="#rid89">
          89
         </a>
         ], intravenous iron prior to pregnancy should be considered if there has been a failure to maintain serum ferritin above 75 mcg/L with oral iron [
         <a href="#rid2">
          2,92
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1914348326">
         <span class="h1">
          PERINATAL MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perinatal management of patients with restless legs syndrome (RLS) is similar to that of the general population. This includes the practice of delayed umbilical cord clamping in vigorous term and preterm infants, which has been shown to improve neonatal and infant iron stores at six months of age and reduce risk of intraventricular hemorrhage in preterm infants. (See
         <a class="medical medical_review" href="/z/d/html/134954.html" rel="external">
          "Labor and delivery: Management of the normal third stage after vaginal birth", section on 'Early versus delayed cord clamping'
         </a>
         .)
        </p>
        <p>
         It is not known whether these benefits translate to reduced risk of RLS in children, but RLS is highly familial and associated with low iron stores in both children and adults. (See
         <a class="medical medical_review" href="/z/d/html/16995.html" rel="external">
          "Restless legs syndrome and periodic limb movement disorder in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2305725252">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112949.html" rel="external">
          "Society guideline links: Restless legs syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1035157302">
         <span class="h1">
          PATIENT PERSPECTIVE TOPIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See
         <a class="medical medical_review" href="/z/d/html/140004.html" rel="external">
          "Patient perspective: Restless legs syndrome first apparent during pregnancy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H111903175">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Restless legs syndrome (RLS) is common during pregnancy, affecting approximately one in five pregnant individuals in Western countries. Symptom severity varies widely, from a minor nuisance in some to a very severe impact on sleep and daytime function in others. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical course
         </strong>
         – RLS typically peaks during the third trimester of pregnancy and markedly improves or remits after delivery. (See
         <a class="local">
          'Clinical course during pregnancy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – Accurate diagnosis is essential  (
         <a class="graphic graphic_table graphicRef86837" href="/z/d/graphic/86837.html" rel="external">
          table 1
         </a>
         ), including the differentiation from other conditions during pregnancy that may mimic RLS, such as leg cramps and positional discomfort  (
         <a class="graphic graphic_table graphicRef100457" href="/z/d/graphic/100457.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – For RLS during pregnancy and lactation, we emphasize reassurance, nonpharmacologic interventions, and iron supplementation for most cases  (
         <a class="graphic graphic_algorithm graphicRef100458" href="/z/d/graphic/100458.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nonpharmacologic therapy
         </strong>
         – Important nonpharmacologic interventions include education about the clinical course of RLS during pregnancy, exercise, and avoidance of exacerbating factors such as prolonged immobility, sleep deprivation, and sedating antihistamines  (
         <a class="graphic graphic_table graphicRef100630" href="/z/d/graphic/100630.html" rel="external">
          table 3
         </a>
         ). Serotonergic antidepressants can induce or aggravate RLS. If present, obstructive sleep apnea should be treated. (See
         <a class="local">
          'First-line therapies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Iron supplementation
         </strong>
         – Iron stores should be assessed in all pregnant individuals with RLS. In those with a serum ferritin below 75 mcg/L, we suggest oral iron supplementation (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). There is no indication for iron supplementation when serum ferritin exceeds 75 mcg/L. Intravenous iron may be considered for patients who have failed oral iron and have a serum ferritin level below 30 mcg/L. (See
         <a class="local">
          'Iron supplementation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Refractory symptoms
         </strong>
         – For refractory RLS that has failed to respond adequately to nonpharmacologic interventions and iron supplementation and has a significant impact on quality of life, we suggest pharmacologic therapy with low-dose
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         or low-dose
         <a class="drug drug_general" data-topicid="8994" href="/z/d/drug information/8994.html" rel="external">
          carbidopa-levodopa
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          Gabapentin
         </a>
         or low-dose clonazepam are the preferred agents during lactation. Medication use should be reassessed periodically, especially after delivery, when RLS symptoms typically subside. (See
         <a class="local">
          'Refractory symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Comorbid depression
         </strong>
         – Depression is commonly comorbid with RLS, and when treatment is required,
         <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">
          bupropion
         </a>
         may have an advantage over serotonergic antidepressants that can exacerbate RLS. (See
         <a class="local">
          'Comorbid depression'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Dunietz GL, Lisabeth LD, Shedden K, et al. Restless Legs Syndrome and Sleep-Wake Disturbances in Pregnancy. J Clin Sleep Med 2017; 13:863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Picchietti DL, Hensley JG, Bainbridge JL, et al. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev 2015; 22:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alves DA, Carvalho LB, Morais JF, Prado GF. Restless legs syndrome during pregnancy in Brazilian women. Sleep Med 2010; 11:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Facco FL, Kramer J, Ho KH, et al. Sleep disturbances in pregnancy. Obstet Gynecol 2010; 115:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darvishi N, Daneshkhah A, Khaledi-Paveh B, et al. The prevalence of Restless Legs Syndrome/Willis-ekbom disease (RLS/WED) in the third trimester of pregnancy: a systematic review. BMC Neurol 2020; 20:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen SJ, Shi L, Bao YP, et al. Prevalence of restless legs syndrome during pregnancy: A systematic review and meta-analysis. Sleep Med Rev 2018; 40:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Na M, Wu J, Li M, et al. New onset of restless legs syndrome in pregnancy in a prospective multiracial cohort: Incidence and risk factors. Neurology 2020; 95:e3438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu G, Li L, Zhang J, et al. Restless legs syndrome and pregnancy or delivery complications in China: a representative survey. Sleep Med 2016; 17:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koo BB. Restless Leg Syndrome Across the Globe: Epidemiology of the Restless Legs Syndrome/Willis-Ekbom Disease. Sleep Med Clin 2015; 10:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panvatvanich S, Lolekha P. Restless Legs Syndrome in Pregnant Thai Women: Prevalence, Predictive Factors, and Natural Course. J Clin Neurol 2019; 15:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshimura C, Arima H, Amagase H, et al. Idiopathic and secondary restless legs syndrome during pregnancy in Japan: Prevalence, clinical features and delivery-related outcomes. PLoS One 2021; 16:e0251298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fawale MB, Ismaila IA, Kullima AA, et al. Restless legs syndrome: a rarity in the Nigerian pregnant population? Sleep Med 2018; 43:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sikandar R, Khealani BA, Wasay M. Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan. Sleep Med 2009; 10:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uglane MT, Westad S, Backe B. Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis. Acta Obstet Gynecol Scand 2011; 90:1046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vahdat M, Sariri E, Miri S, et al. Prevalence and associated features of restless legs syndrome in a population of Iranian women during pregnancy. Int J Gynaecol Obstet 2013; 123:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minar M, Habanova H, Rusnak I, et al. Prevalence and impact of restless legs syndrome in pregnancy. Neuro Endocrinol Lett 2013; 34:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shang X, Yang J, Guo Y, et al. Restless legs syndrome among pregnant women in China: prevalence and risk factors. Sleep Breath 2015; 19:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miri S, Rohani M, Vahdat M, et al. Presenting features of idiopathic versus secondary restless legs syndrome in pregnancy. Iran J Neurol 2014; 13:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mubeen SM, Ahsan MD. Prevalence and associated factors of restless leg syndrome (RLS) in Pakistani women during pregnancy. J Obstet Gynaecol 2022; 42:1829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neyal A, Senel GB, Aslan R, et al. A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy. Sleep Med 2015; 16:1036.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hennessy MD, De La Torre FA. Heredity of restless legs syndrome in a pregnant population. J Obstet Gynecol Neonatal Nurs 2013; 42:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esposito G, Odelli V, Romiti L, et al. Prevalence and risk factors for restless legs syndrome during pregnancy in a Northern Italian population. J Obstet Gynaecol 2019; 39:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Telarović S, Čondić L. Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome. Hematology 2019; 24:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abedi P, Bagheri R, Qorbani M, Ansari S. Is there a relationship between restless legs syndrome and medical problems in pregnant women? A cross-sectional study in Iran. Acta Neurol Belg 2020; 120:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turan H, Aşkın Turan S, Butun Z, Kayapınar M. The Prevalence, Severity, and Predictive Factors of Restless Legs Syndrome in Pregnancy. Cureus 2023; 15:e44884.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manconi M, Ulfberg J, Berger K, et al. When gender matters: restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group. Sleep Med Rev 2012; 16:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pereira JC Jr, Rocha e Silva IR, Pradella-Hallinan M. Transient Willis-Ekbom's disease (restless legs syndrome) during pregnancy may be caused by estradiol-mediated dopamine overmodulation. Med Hypotheses 2013; 80:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minár M, Košutzká Z, Habánová H, et al. Restless legs syndrome in pregnancy is connected with iron deficiency. Sleep Med 2015; 16:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prosperetti C, Manconi M. Restless Legs Syndrome/Willis-Ekbom Disease and Pregnancy. Sleep Med Clin 2015; 10:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Telarovic S, Condic L. Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome. Hematology 2019; 24:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyazaki A, Takahashi M, Shuo T, et al. Determination of optimal 25-hydroxyvitamin D cutoff values for the evaluation of restless legs syndrome among pregnant women. J Clin Sleep Med 2023; 19:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akbaş P, Sözbir ŞY. Restless legs syndrome and quality of life in pregnant women. Rev Assoc Med Bras (1992) 2019; 65:618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hübner A, Krafft A, Gadient S, et al. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013; 80:738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manconi M, van der Gaag LC, Mangili F, et al. Sleep and sleep disorders during pregnancy and postpartum: The Life-ON study. Sleep Med 2024; 113:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neau JP, Porcheron A, Mathis S, et al. Restless legs syndrome and pregnancy: a questionnaire study in the Poitiers District, France. Eur Neurol 2010; 64:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kızılırmak A, Timur S, Kartal B. Insomnia in pregnancy and factors related to insomnia. ScientificWorldJournal 2012; 2012:197093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan M, Mobeireek N, Al-Jahdali Y, et al. The prevalence of restless leg syndrome among pregnant Saudi women. Avicenna J Med 2018; 8:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manconi M, Govoni V, De Vito A, et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004; 5:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodman JD, Brodie C, Ayida GA. Restless leg syndrome in pregnancy. BMJ 1988; 297:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cesnik E, Casetta I, Turri M, et al. Transient RLS during pregnancy is a risk factor for the chronic idiopathic form. Neurology 2010; 75:2117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howe LD, Signal TL, Paine SJ, et al. Self-reported sleep in late pregnancy in relation to birth size and fetal distress: the E Moe, Māmā prospective cohort study. BMJ Open 2015; 5:e008910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuna Oran N, Yuksel E, Ruzgar S. Prevalence of restless leg syndrome and effects on quality of life during pregnancy. Sleep Breath 2021; 25:2127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lu Q, Zhang X, Wang Y, et al. Sleep disturbances during pregnancy and adverse maternal and fetal outcomes: A systematic review and meta-analysis. Sleep Med Rev 2021; 58:101436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinweg K, Nippita T, Cistulli PA, Bin YS. Maternal and neonatal outcomes associated with restless legs syndrome in pregnancy: A systematic review. Sleep Med Rev 2020; 54:101359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sevim S, Dogu O, Kaleagasi H, et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004; 75:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005; 28:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005; 252:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008; 20:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho SJ, Hong JP, Hahm BJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 2009; 32:1069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006; 7:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Becker PM, Sharon D. Mood disorders in restless legs syndrome (Willis-Ekbom disease). J Clin Psychiatry 2014; 75:e679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 2001; 10:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wesström J, Skalkidou A, Manconi M, et al. Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression. J Clin Sleep Med 2014; 10:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarberg M, Bladh M, Svanborg E, Josefsson A. Postpartum depressive symptoms and its association to daytime sleepiness and restless legs during pregnancy. BMC Pregnancy Childbirth 2016; 16:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yıldırım E, Apaydın H. Zinc and Magnesium Levels of Pregnant Women with Restless Leg Syndrome and Their Relationship with Anxiety: A Case-Control Study. Biol Trace Elem Res 2021; 199:1674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 2014; 15:860.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, text revision, American Academy of Sleep Medicine, 2023.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hening WA, Allen RP, Washburn M, et al. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med 2009; 10:976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller MA, Mehta N, Clark-Bilodeau C, Bourjeily G. Sleep Pharmacotherapy for Common Sleep Disorders in Pregnancy and Lactation. Chest 2020; 157:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garbazza C, Manconi M. Management Strategies for Restless Legs Syndrome/Willis-Ekbom Disease During Pregnancy. Sleep Med Clin 2018; 13:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramoz LL, Patel-Shori NM. Recent changes in pregnancy and lactation labeling: retirement of risk categories. Pharmacotherapy 2014; 34:389.
          </a>
         </li>
         <li class="breakAll">
          Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 11th ed, Lippincott Williams &amp; Wilkins, Philadelphia, PA 2017.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aukerman MM, Aukerman D, Bayard M, et al. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2006; 19:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deslandes A, Moraes H, Ferreira C, et al. Exercise and mental health: many reasons to move. Neuropsychobiology 2009; 59:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giannaki CD, Sakkas GK, Karatzaferi C, et al. Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol 2013; 14:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koltyn KF, Schultes SS. Psychological effects of an aerobic exercise session and a rest session following pregnancy. J Sports Med Phys Fitness 1997; 37:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connolly CP, Conger SA, Montoye AHK, et al. Walking for health during pregnancy: A literature review and considerations for future research. J Sport Health Sci 2019; 8:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia-Borreguero D, Stillman P, Benes H, et al. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol 2011; 11:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical update. Chest 2006; 130:1596.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005; 58:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008; 43:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones CR. Diagnostic and management approach to common sleep disorders during pregnancy. Clin Obstet Gynecol 2013; 56:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delgado Rodrigues RN, Alvim de Abreu E Silva Rodrigues AA, Pratesi R, Krieger J. Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas. Sleep Med 2006; 7:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silva C, Peralta AR, Bentes C. The urge to move and breathe - the impact of obstructive sleep apnea syndrome treatment in patients with previously diagnosed, clinically significant restless legs syndrome. Sleep Med 2017; 38:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silber MH, Buchfuhrer MJ, Earley CJ, et al. The Management of Restless Legs Syndrome: An Updated Algorithm. Mayo Clin Proc 2021; 96:1921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sönmez A, Aksoy Derya Y. Effects of sleep hygiene training given to pregnant women with restless leg syndrome on their sleep quality. Sleep Breath 2018; 22:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Innes KE, Selfe TK. The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial. Evid Based Complement Alternat Med 2012; 2012:294058.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Innes KE, Selfe TK, Agarwal P, et al. Efficacy of an eight-week yoga intervention on symptoms of restless legs syndrome (RLS): a pilot study. J Altern Complement Med 2013; 19:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell M. Massage therapy and restless legs syndrome. J Bodyw Mov Ther 2007; 11:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuellar N, Galper DI, Taylor AG, et al. Restless legs syndrome. J Altern Complement Med 2004; 10:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest 2009; 135:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eliasson AH, Lettieri CJ. Sequential compression devices for treatment of restless legs syndrome. Medicine (Baltimore) 2007; 86:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajaram SS, Rudzinskiy P, Walters AS. Enhanced external counter pulsation (EECP) for restless legs syndrome (RLS): preliminary negative results in a parallel double-blind study. Sleep Med 2006; 7:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajaram SS, Shanahan J, Ash C, et al. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Sleep Med 2005; 6:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guay A, Houle M, O'Shaughnessy J, Descarreaux M. Current Evidence on Diagnostic Criteria, Relevant Outcome Measures, and Efficacy of Nonpharmacologic Therapy in the Management of Restless Legs Syndrome (RLS): A Scoping Review. J Manipulative Physiol Ther 2020; 43:930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akbaş P, Yaman Sözbir Ş. The effect of progressive muscle relaxation exercise on the intensity of symptoms and quality of sleep and quality of life in pregnant women with restless leg syndrome. Patient Educ Couns 2023; 113:107768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jafarimanesh H, Vakilian K, Mobasseri S. Thermo-therapy and cryotherapy to decrease the symptoms of restless leg syndrome during the pregnancy: A randomized clinical trial. Complement Ther Med 2020; 50:102409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000; 72:257S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavord S, Myers B, Robinson S, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2012; 156:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med 2018; 41:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Picchietti DL, Wang VC, Picchietti MA. Intravenous iron given prior to pregnancy for restless legs syndrome is associated with remission of symptoms. J Clin Sleep Med 2012; 8:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vadasz D, Ries V, Oertel WH. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin. Sleep Med 2013; 14:1214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider J, Krafft A, Manconi M, et al. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome. Sleep Med 2015; 16:1342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aynaci G, Guksu Z. The effects of dietary folate and iron supplementation on restless legs and preeclampsia in pregnancy. Prog Nutr 2019; 21:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eskeland B, Baerheim A, Ulvik R, Hunskaar S. Influence of mild infections on iron status parameters in women of reproductive age. Scand J Prim Health Care 2002; 20:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol 2017; 4:e524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2012; :CD009997.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hyacinthe C, De Deurwaerdere P, Thiollier T, et al. Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function. Neuroscience 2015; 290:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swaney P, Thorp J, Allen I. Vitamin C supplementation in pregnancy--does it decrease rates of preterm birth? A systematic review. Am J Perinatol 2014; 31:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barton JC, Wooten VD, Acton RT. Hemochromatosis and iron therapy of Restless Legs Syndrome. Sleep Med 2001; 2:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaughnessy P, Lee J, O'Keeffe ST. Restless legs syndrome in patients with hereditary hemochromatosis. Neurology 2005; 64:2158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christoph P, Schuller C, Studer H, et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med 2012; 40:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong L, Smith S, Gilstrop M, et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol 2016; 91:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001; 11:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montagna P, Sassoli de Bianchi L, Zucconi M, et al. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984; 69:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinstock L, Cohen LS, Bailey JW, et al. Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom 2001; 70:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin AE, Peller AJ, Westgate MN, et al. Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res A Clin Mol Teratol 2004; 70:534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eros E, Czeizel AE, Rockenbauer M, et al. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2002; 101:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samrén EB, van Duijn CM, Christiaens GC, et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dostal M, Weber-Schoendorfer C, Sobesky J, Schaefer C. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. Eur J Neurol 2013; 20:1241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watanabe T, Matsubara S, Baba Y, et al. Successful management of pregnancy in a patient with Segawa disease: case report and literature review. J Obstet Gynaecol Res 2009; 35:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serikawa T, Shimohata T, Akashi M, et al. Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism. BMC Neurol 2011; 11:72.
          </a>
         </li>
         <li class="breakAll">
          Micromedex Inc. Micromedex healthcare series. Englewood, CO: Micromedex.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silber MH, Becker PM, Earley C, et al. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc 2013; 88:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cornelius JR, Tippmann-Peikert M, Slocumb NL, et al. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010; 33:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silber MH, Becker PM, Buchfuhrer MJ, et al. The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome. Mayo Clin Proc 2018; 93:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veroniki AA, Rios P, Cogo E, et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open 2017; 7:e017248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weston J, Bromley R, Jackson CF, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2016; 11:CD010224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bromley R, Weston J, Adab N, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014; :CD010236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohman I, Tomson T. Gabapentin kinetics during delivery, in the neonatal period, and during lactation. Epilepsia 2009; 50:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 2005; 46:1621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kristensen JH, Ilett KF, Hackett LP, Kohan R. Gabapentin and breastfeeding: a case report. J Hum Lact 2006; 22:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly LE, Poon S, Madadi P, Koren G. Neonatal benzodiazepines exposure during breastfeeding. J Pediatr 2012; 161:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series. Pediatrics 1999; 104:e11.
          </a>
         </li>
         <li class="breakAll">
          US Food and Drug Administration Drug Safety Communications. FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. https://www.fda.gov/downloads/Drugs/DrugSafety/UCM553814.pdf (Accessed on April 24, 2017).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010; 24:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hornyak M, Kopasz M, Berger M, et al. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry 2005; 66:1139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benes H, Mattern W, Peglau I, et al. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study. J Neurol 2011; 258:1046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fulda S, Kloiber S, Dose T, et al. Mirtazapine provokes periodic leg movements during sleep in young healthy men. Sleep 2013; 36:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bayard M, Bailey B, Acharya D, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2011; 24:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nofzinger EA, Fasiczka A, Berman S, Thase ME. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry 2000; 61:858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 2009; 31:403.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 98366 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28633715" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Restless Legs Syndrome and Sleep-Wake Disturbances in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25553600" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20947424" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Restless legs syndrome during pregnancy in Brazilian women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20027038" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Sleep disturbances in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32284042" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The prevalence of Restless Legs Syndrome/Willis-ekbom disease (RLS/WED) in the third trimester of pregnancy: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29169861" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Prevalence of restless legs syndrome during pregnancy: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33177224" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : New onset of restless legs syndrome in pregnancy in a prospective multiracial cohort: Incidence and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26847992" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Restless legs syndrome and pregnancy or delivery complications in China: a representative survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26329429" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Restless Leg Syndrome Across the Globe: Epidemiology of the Restless Legs Syndrome/Willis-Ekbom Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30618223" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Restless Legs Syndrome in Pregnant Thai Women: Prevalence, Predictive Factors, and Natural Course.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33974646" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Idiopathic and secondary restless legs syndrome during pregnancy in Japan: Prevalence, clinical features and delivery-related outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29482812" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Restless legs syndrome: a rarity in the Nigerian pregnant population?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19110469" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21504414" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23886452" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prevalence and associated features of restless legs syndrome in a population of Iranian women during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23922045" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Prevalence and impact of restless legs syndrome in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25450154" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Restless legs syndrome among pregnant women in China: prevalence and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25632338" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Presenting features of idiopathic versus secondary restless legs syndrome in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35476609" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prevalence and associated factors of restless leg syndrome (RLS) in Pakistani women during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26298776" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24128048" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Heredity of restless legs syndrome in a pregnant population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30620232" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Prevalence and risk factors for restless legs syndrome during pregnancy in a Northern Italian population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31793405" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30542964" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Is there a relationship between restless legs syndrome and medical problems in pregnant women? A cross-sectional study in Iran.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37692184" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The Prevalence, Severity, and Predictive Factors of Restless Legs Syndrome in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22075215" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : When gender matters: restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23257652" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Transient Willis-Ekbom's disease (restless legs syndrome) during pregnancy may be caused by estradiol-mediated dopamine overmodulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25900141" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Restless legs syndrome in pregnancy is connected with iron deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26329442" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Restless Legs Syndrome/Willis-Ekbom Disease and Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35999809" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Determination of optimal 25-hydroxyvitamin D cutoff values for the evaluation of restless legs syndrome among pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31166437" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Restless legs syndrome and quality of life in pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23390174" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37984016" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Sleep and sleep disorders during pregnancy and postpartum: The Life-ON study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20980760" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Restless legs syndrome and pregnancy: a questionnaire study in the Poitiers District, France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22623880" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Insomnia in pregnancy and factors related to insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29404269" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The prevalence of restless leg syndrome among pregnant Saudi women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15165540" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Pregnancy as a risk factor for restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3143441" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Restless leg syndrome in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21135386" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Transient RLS during pregnancy is a risk factor for the chronic idiopathic form.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26438138" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Self-reported sleep in late pregnancy in relation to birth size and fetal distress: the E Moe, Māmāprospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33566234" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Prevalence of restless leg syndrome and effects on quality of life during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33571887" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Sleep disturbances during pregnancy and adverse maternal and fetal outcomes: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32805557" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Maternal and neonatal outcomes associated with restless legs syndrome in pregnancy: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14742594" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16124671" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Restless legs syndrome, periodic limb movements in sleep, and depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15654556" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18305292" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19725258" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16740407" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25093484" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Mood disorders in restless legs syndrome (Willis-Ekbom disease).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11445024" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24812538" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27267900" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Postpartum depressive symptoms and its association to daytime sleepiness and restless legs during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32676936" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Zinc and Magnesium Levels of Pregnant Women with Restless Leg Syndrome and Their Relationship with Anxiety: A Case-Control Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25023924" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25023924" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14592342" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19185537" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics").
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31622589" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Sleep Pharmacotherapy for Common Sleep Disorders in Pregnancy and Lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30098751" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Management Strategies for Restless Legs Syndrome/Willis-Ekbom Disease During Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24390829" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Recent changes in pregnancy and lactation labeling: retirement of risk categories.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24390829" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Recent changes in pregnancy and lactation labeling: retirement of risk categories.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16951298" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Exercise and restless legs syndrome: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19521110" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Exercise and mental health: many reasons to move.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24024727" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9509828" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Psychological effects of an aerobic exercise session and a rest session following pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31534815" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Walking for health during pregnancy: A literature review and considerations for future research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21352569" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Algorithms for the diagnosis and treatment of restless legs syndrome in primary care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17099042" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Restless legs syndrome: a clinical update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16005440" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Antidepressants and periodic leg movements of sleep.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18468624" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Restless legs syndrome as side effect of second generation antidepressants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23563879" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Diagnostic and management approach to common sleep disorders during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16564217" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29031750" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : The urge to move and breathe - the impact of obstructive sleep apnea syndrome treatment in patients with previously diagnosed, clinically significant restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34218864" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The Management of Restless Legs Syndrome: An Updated Algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29332218" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Effects of sleep hygiene training given to pregnant women with restless leg syndrome on their sleep quality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22474497" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23270319" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Efficacy of an eight-week yoga intervention on symptoms of restless legs syndrome (RLS): a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Massage therapy and restless legs syndrome
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15253844" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19017878" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18004176" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Sequential compression devices for treatment of restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16713348" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Enhanced external counter pulsation (EECP) for restless legs syndrome (RLS): preliminary negative results in a parallel double-blind study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15716213" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32900545" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Current Evidence on Diagnostic Criteria, Relevant Outcome Measures, and Efficacy of Nonpharmacologic Therapy in the Management of Restless Legs Syndrome (RLS): A Scoping Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37146530" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The effect of progressive muscle relaxation exercise on the intensity of symptoms and quality of sleep and quality of life in pregnant women with restless leg syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32444058" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Thermo-therapy and cryotherapy to decrease the symptoms of restless leg syndrome during the pregnancy: A randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10871591" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Iron requirements in pregnancy and strategies to meet them.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22512001" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : UK guidelines on the management of iron deficiency in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29425576" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23066374" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Intravenous iron given prior to pregnancy for restless legs syndrome is associated with remission of symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24012019" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26498233" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : The effects of dietary folate and iron supplementation on restless legs and preeclampsia in pregnancy
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12086285" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Influence of mild infections on iron status parameters in women of reproductive age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29032957" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22786531" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Intermittent oral iron supplementation during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25662508" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23508703" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Vitamin C supplementation in pregnancy--does it decrease rates of preterm birth? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11311689" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Hemochromatosis and iron therapy of Restless Legs Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15985601" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Restless legs syndrome in patients with hereditary hemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22945271" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26971581" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11313161" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6380197" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Clonazepam and vibration in restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11340418" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15329832" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Clonazepam use in pregnancy and the risk of malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11858890" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10553991" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Antiepileptic drug regimens and major congenital abnormalities in the offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23083216" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19527400" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Successful management of pregnancy in a patient with Segawa disease: case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21682904" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21682904" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24001490" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20120624" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29304922" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28729328" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27819746" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25354543" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Gabapentin kinetics during delivery, in the neonatal period, and during lactation
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16190933" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17062788" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Gabapentin and breastfeeding: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22504099" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Neonatal benzodiazepines exposure during breastfeeding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10390297" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10390297" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20088617" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16187772" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21188406" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23633748" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Mirtazapine provokes periodic leg movements during sleep in young healthy men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21737767" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Bupropion and restless legs syndrome: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11105739" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19703633" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
